Cite
HARVARD Citation
Shapira, S. et al. (2022). A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond. EMBO molecular medicine. 14 (9), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shapira, S. et al. (2022). A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond. EMBO molecular medicine. 14 (9), p. n/a. [Online].